The lncRNA taurine up-regulated 1 (TUG1) has been shown to regulate glycolysis and metastasis in HCC through hexokinase 2 (HK2), and thereby provides a potential therapeutic strategy of targeting TUG1 for treatment of HCC [100]. The gene discussed is HK2; the disease is hepatocellular carcinoma.